PONTE VEDRA, Fla., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related ...
PONTE VEDRA, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the ...
The system features an outrigger designed for controlled tri-planar correction including translation and derotation of the metatarsal head and adjustment of the distal metatarsal articular angle.
The Percuplasty™ System provides an instrumented, reproducible approach to 3D correction of the bunion deformity through cosmetically appealing, percutaneous incisions designed to minimize post-op ...
John Treace: Yes, Simon. John, here. It’s really not one competitor per se, but it’s an amalgamation of a number of competitors, big companies, small companies, public and private, that are now ...
Stifel Nicolaus analyst Rick Wise downgraded the rating on Treace Medical Concepts (TMCI – Research Report) to a Hold today, setting a price target of $6.00. Rick Wise has given his Hold rating due to ...
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NASDAQ: TMCI) on behalf of investors concerning ...
Treace Medical Concepts, Inc. beats earnings expectations. Reported EPS is $-0.25, expectations were $-0.27. Operator: Good day and thank you for standing by. Welcome to the Treace Medical Concepts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback